Literature DB >> 7821973

MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production.

M Wahren1, K Skarstein, I Blange, I Pettersson, R Jonsson.   

Abstract

MRL/lpr mice are studied as one of the animal models of the human autoimmune disease Sjögren's syndrome. The mice develop inflammatory exocrinopathy resembling that of patients with Sjögren's syndrome. To investigate if MRL/lpr mice produce the anti-Ro/SS-A and anti-La/SS-B autoantibodies common to Sjögren's syndrome patients, mouse sera were tested in ELISA and Western blot with recombinant Ro 60,000 MW, Ro 52,000 MW and La antigen. Thirty per cent of mice aged 4 months and 5% of mice aged 2 months produced antibodies to human Ro 52,000 MW. Antibodies to Ro 60,000 MW and La were found in a low percentage of the older mice but not at all in the younger mice. Immunohistological staining of mouse organ sections demonstrated anti-Ro 52,000 MW-producing cells in spleen, lymph nodes and salivary glands of seropositive animals. These findings provide further evidence for the usefulness of the MRL/lpr mouse as a model for Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821973      PMCID: PMC1415008     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

Review 3.  Antibody production by hybridomas.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen.

Authors:  M Mattioli; M Reichlin
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

5.  Identification of antigenic regions of the human Ro 60 kDa protein using recombinant antigen and synthetic peptides.

Authors:  M Wahren; U Rudén; B Andersson; N R Ringertz; I Pettersson
Journal:  J Autoimmun       Date:  1992-06       Impact factor: 7.094

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Precursor molecules of both human 5S ribosomal RNA and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies.

Authors:  J Rinke; J A Steitz
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

8.  Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease.

Authors:  E A Lerner; M R Lerner; C A Janeway; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs.

Authors:  S L Wolin; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Presence of anti-Sm reactivity in autoimmune mouse strains.

Authors:  R A Eisenberg; E M Tan; F J Dixon
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Horizons in Sjögren's syndrome genetics.

Authors:  Pamela H Williams; Beth L Cobb; Bahram Namjou; R Hal Scofield; Amr H Sawalha; John B Harley
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  Sjögren's syndrome: an old tale with a new twist.

Authors:  Byung Ha Lee; Mauro A Tudares; Cuong Q Nguyen
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

Review 3.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

4.  Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; M Wahren-Herlenius; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; J B Harley; U Kroneld; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 6.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

7.  Heterogeneity of human Ro ribonucleoproteins (RNPS): nuclear retention of Ro RNPS containing the human hY5 RNA in human and mouse cells.

Authors:  M Gendron; D Roberge; G Boire
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

8.  STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren's syndrome.

Authors:  Kwong Tai Cheng; Ilias Alevizos; Xibao Liu; Wiliam D Swaim; Hongen Yin; Stefan Feske; Masatsugu Oh-hora; Indu S Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

Review 9.  Sjögren syndrome: what and where are we looking for?

Authors:  Cintia S de Paiva; Eduardo Melani Rocha
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

10.  Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice.

Authors:  A C Horsfall; R Howson; P Silveira; D G Williams; A G Baxter
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.